D57.439
Sickle-cell thalassemia beta zero with crisis, unspecified
Clinical Classification Guidelines
Inclusion Terms
- HbS-beta zero with other specified complication
- Sickle-cell beta zero with crisis unspecified
- Sickle-cell thalassemia beta zero with (painful) crisis NOS
- Sickle-cell thalassemia beta zero with (vaso-occlusive) pain NOS
Medical Intelligence & Overview
Sickle-cell thalassemia beta zero with crisis is a genetic blood disorder characterized by abnormal hemoglobin, leading to the destruction of red blood cells and causing severe health complications. This condition involves a specific form of sickle-cell disease combined with beta-thalassemia, resulting in a complex disease pattern that can cause episodes known as crises. These crises are painful events resulting from blockages in blood flow due to misshapen red blood cells. The term 'unspecified' indicates that the precise details of the crisis have not been specified or classified further.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations affecting hemoglobin production Presence of sickle-cell hemoglobin (HbS) combined with beta-zero thalassemia gene Inheritance from both parents carrying gene mutations related to sickle-cell disease and beta-thalassemia Triggers that can precipitate crises include infections, dehydration, extreme temperatures, physical or emotional stress, or high altitudes
Key Symptoms: Severe episodes of pain, often in the chest, limbs, or abdomen Swelling in hands and feet Fatigue and weakness due to anemia Paleness or jaundice (yellowing of the skin and eyes) Frequent infections Delayed growth or puberty in children Vision problems due to damage in the small blood vessels of the eyes
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to assess anemia Hemoglobin electrophoresis to identify abnormal hemoglobin types Genetic testing to detect beta-zero thalassemia and sickle-cell mutations Blood smear microscopy to observe the shape of red blood cells Imaging studies like MRI or ultrasound if organ damage is suspected
Treatment Protocols: Pain management during crises with medications such as analgesics Hydration therapy to prevent sickling of red blood cells Blood transfusions to treat severe anemia and reduce sickled cells Medications like hydroxyurea to reduce the frequency and severity of crises Prompt treatment of infections to prevent triggers Regular monitoring of organ function and blood counts Bone marrow or stem cell transplants in select cases as a potential cure
Clinical Advice & FAQs
Billing Guidance
Is D57.439 a billable ICD-10 code?
Yes, D57.439 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.439?
Clinical documentation must specify the nature of Sickle-cell thalassemia beta zero with crisis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference